- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Osimertinib Mesylate
Total 1886 results
-
Sun Yat-sen UniversityRecruiting
-
Mark VincentAstraZenecaRecruitingNon-Small Cell Lung CancerCanada
-
AstraZenecaCompletedNon-small Cell Lung CancerSweden
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Eisai Inc.Completed
-
Eisai Inc.Children's Oncology GroupCompleted
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)UnknownAdvanced Breast Cancer | Metastatic Breast CancerTaiwan
-
Eisai Co., Ltd.Completed
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusGermany, Portugal, Spain, United Kingdom, Austria
-
Eisai Inc.Completed
-
Seoul National University HospitalRecruitingAdvanced Breast CancerKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusUnited States, Austria, Germany, Brazil, Mexico
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusBelgium, Czech Republic, France, Poland, South Africa, Netherlands
-
LianBio LLCRecruiting
-
Shanghai JMT-Bio Inc.Active, not recruitingLocal Advanced or Metastatic NSCLC | Harboring EGFR Common MutationChina
-
Cancer Research UKLatus TherapeuticsTerminatedCOVID-19 InfectionUnited Kingdom
-
InteKrin Therapeutics, Inc.CompletedDiabetes Mellitus, Type IIUnited States
-
Hunan Cancer HospitalCompletedMetastatic Breast CancerChina
-
Oncologia Medica dell'Ospedale FatebenefratelliMario Negri Institute for Pharmacological ResearchCompletedMetastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug ToxicityItaly
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
CelgeneCompletedHepatic ImpairmentUnited States
-
CelgeneCompletedHepatic ImpairmentUnited States
-
Tianjin Medical University Cancer Institute and...RecruitingNon-small Cell Lung Cancer | EGFR Activating Mutation | EGFR-TKI Resistant Mutation | Cell Cycle DeregulationChina
-
AstraZenecaHutchison MediPharmaRecruitingCarcinomaDenmark, Spain, United States, Taiwan, Vietnam, Canada, Korea, Republic of, Brazil, India, Japan, Italy, Puerto Rico, France, Chile
-
Nantes University HospitalAstraZenecaActive, not recruitingNon-small Cell Lung CancerFrance
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
M.D. Anderson Cancer CenterWithdrawn
-
Zhejiang Cancer HospitalNot yet recruiting
-
UConn HealthNational Institute on Aging (NIA); University of ConnecticutNot yet recruitingFrailty | Aging | Mild Cognitive ImpairmentUnited States
-
Eisai Inc.Completed
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedChronic Myeloid LeukemiaChina
-
Integrative Skin Science and ResearchActeraNot yet recruitingHyperpigmentation | Acne | Post-inflammatory Hyperpigmentation
-
Ball State UniversityCompletedAging | Endothelial Dysfunction | Arterial Stiffness | Cardiovascular FunctionUnited States
-
Samsung Medical CenterRecruitingLung AdenocarcinomaKorea, Republic of
-
Revolution Medicines, Inc.SanofiCompletedSolid TumorUnited States, Korea, Republic of
-
Genprex, Inc.RecruitingCarcinoma, Non-Small Cell LungUnited States
-
Sagent Pharmaceuticals Inc.Completed
-
Esanex Inc.National Cancer Institute (NCI)CompletedLymphoma | Leukemia | Solid Tumor Malignancy | Lymphoid Malignancy (Lymphoma and CLL)United States
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
National Cancer Institute (NCI)CompletedLung Neoplasms | Lung AdenocarcinomaUnited States
-
AstraZenecaRecruitingCarcinoma, Non-Small-Cell LungUnited States, China, Korea, Republic of, Canada, Italy, Poland, Spain, Belgium, Netherlands, Japan, Germany, Brazil, Turkey, Russian Federation, United Kingdom, Greece, Israel, Australia, France, Puerto Rico
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
University of Colorado, DenverCancer League of ColoradoCompletedNon Small Cell Lung Cancer | CNS ProgressionUnited States
-
Hutchison Medipharma LimitedRecruitingNon-small Cell Lung CancerChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingHER2-negative Breast CancerChina
-
Eisai Co., Ltd.CompletedInoperable or Recurrent Breast CancerJapan